freddiegbruh

ETNB long (longer-term play)

Long
NASDAQ:ETNB   89bio, Inc
ETNB long, longer-term play

89bio , Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01 , 2018 and is headquartered in San Francisco, CA.

Pre-revenue, early stage company.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.